tiprankstipranks
Trending News
More News >
Physitrack Limited (SE:PTRK)
:PTRK
Sweden Market
Advertisement

Physitrack Limited (PTRK) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

PTRK Financial Forecast

PTRK Earnings Forecast

The previous quarter’s earnings for PTRK were -kr0.11.
The previous quarter’s earnings for PTRK were -kr0.11.

PTRK Sales Forecast

Next quarter’s sales forecast for PTRK is kr43.71M with a range of kr43.71M to kr43.71M. The previous quarter’s sales results were kr38.45M. PTRK beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year PTRK has Preformed in-line its overall industry.
Next quarter’s sales forecast for PTRK is kr43.71M with a range of kr43.71M to kr43.71M. The previous quarter’s sales results were kr38.45M. PTRK beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year PTRK has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on SE:PTRK
TR | OpenAI - 4o
TR | OpenAI - 4o
kr17.5kr15
Hold
0.00%
Upside
Reiterated
10/22/25
AI Generated ArticleAI Generated Article
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on SE:PTRK
TR | OpenAI - 4o
TR | OpenAI - 4o
kr17.5kr15
Hold
0.00%
Upside
Reiterated
10/22/25
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

PTRK Analyst Recommendation Trends

Rating
Jul 25
Aug 25
Strong Buy
0
0
Buy
0
0
Hold
9
11
Sell
0
0
Strong Sell
0
0
total
9
11
In the current month, PTRK has received 0 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. PTRK average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

PTRK Stock Forecast FAQ

What is SE:PTRK’s average 12-month price target, according to analysts?
Currently, no data Available
What is SE:PTRK’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SE:PTRK, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Physitrack Limited a Buy, Sell or Hold?
      Physitrack Limited has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
        What is Physitrack Limited’s share price target?
        Currently, no data Available
        What do analysts say about Physitrack Limited?
        Physitrack Limited’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
          How can I buy shares of Physitrack Limited?
          To buy shares of SE:PTRK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis